Kirill Osipov comments on regulation of dependent inventions in Russia

Kirill Osipov, the Head of Legal Department of ARS-Patent, commented on regulation of dependent inventions in Russia for the newspaper “Pharmvestnik” in the light of the Moscow Arbitration Court’s Decision of June 1, 2018, according to which, a first compulsory license may be granted in Russia to a medicament comprising INN Lenalidomide.

More details are available at Pharmvestnik’s website.

Pharmvestnik is the leading specialized weekly newspaper covering the Russian pharmaceutical and related industries with a circulation of 16 200 copies. The newspaper has been issued since 1994.

Make an enquiry